1,638
Views
9
CrossRef citations to date
0
Altmetric
Review

New insights into rotavirus vaccines

, &
Pages 1022-1028 | Received 25 Feb 2012, Accepted 08 Apr 2012, Published online: 01 Aug 2012

References

  • Centers for Disease Control and Prevention (CDC). Rotavirus surveillance --- worldwide, 2009. MMWR Morb Mortal Wkly Rep 2011; 60:514 - 6; PMID: 21527889
  • Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136 - 41; http://dx.doi.org/10.1016/S1473-3099(11)70253-5; PMID: 22030330
  • Word Heath Organization. Decision making and Implementation of Rotavirus Vaccines http://www.who.int/nuvi/rotavirus/decision_implementation/en/index.html. Accessed 22th January 2012.
  • Ward RL, McNeal MM, Steele AD. Why does the world need another rotavirus vaccine?. Ther Clin Risk Manag 2008; 4:49 - 63; PMID: 18728720
  • O’Ryan M, Linhares AC. Update on Rotarix: an oral human rotavirus vaccine. Expert Rev Vaccines 2009; 8:1627 - 41; http://dx.doi.org/10.1586/erv.09.136; PMID: 19943758
  • Chandran A, Santosham M. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine. Expert Rev Vaccines 2008; 7:1475 - 80; http://dx.doi.org/10.1586/14760584.7.10.1475; PMID: 19053204
  • Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 2008; 46:1664 - 72; http://dx.doi.org/10.1086/587897; PMID: 18433334
  • Hargreaves RM, Slack MP, Howard AJ, Anderson E, Ramsay ME. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 1996; 312:160 - 1; http://dx.doi.org/10.1136/bmj.312.7024.160; PMID: 8563536
  • Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11:557 - 70; http://dx.doi.org/10.1016/S1473-3099(11)70007-X; PMID: 21600850
  • Tsou TP, Liu CC, Huang JJ, Tsai KJ, Chang HF. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008. Vaccine 2011; 29:2956 - 61; http://dx.doi.org/10.1016/j.vaccine.2011.02.001; PMID: 21329774
  • Goodson JL, Masresha BG, Wannemuehler K, Uzicanin A, Cochi S. Changing epidemiology of measles in Africa. J Infect Dis 2011; 204:Suppl 1 S205 - 14; http://dx.doi.org/10.1093/infdis/jir129; PMID: 21666163
  • Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, et al. Changing varicella epidemiology in active surveillance sites--United States, 1995-2005. J Infect Dis 2008; 197:Suppl 2 S71 - 5; http://dx.doi.org/10.1086/522156; PMID: 18419413
  • Skoff TH, Cohn AC, Clark TA, Messonnier NE, Martin SW. Early Impact of the US Tdap Vaccination Program on Pertussis Trends. Arch Pediatr Adolesc Med 2012; 166:344 - 9; http://dx.doi.org/10.1001/archpediatrics.2011.1093; PMID: 22213608
  • de Blasio BF, Kasymbekova K, Flem E. Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan. Vaccine 2010; 28:7923 - 32; http://dx.doi.org/10.1016/j.vaccine.2010.09.070; PMID: 20933563
  • Pitzer VE, Viboud C, Simonsen L, Steiner C, Panozzo CA, Alonso WJ, et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 2009; 325:290 - 4; http://dx.doi.org/10.1126/science.1172330; PMID: 19608910
  • Clark HF, Lawley D, Matthijnssens J, DiNubile MJ, Hodinka RL. Sustained decline in cases of rotavirus gastroenteritis presenting to the Children’s Hospital of Philadelphia in the new rotavirus vaccine era. Pediatr Infect Dis J 2010; 29:699 - 702; http://dx.doi.org/10.1097/INF.0b013e3181d73524; PMID: 20661099
  • Hanquet G, Ducoffre G, Vergison A, Neels P, Sabbe M, Van Damme P, et al. Impact of rotavirus vaccination on laboratory confirmed cases in Belgium. Vaccine 2011; 29:4698 - 703; http://dx.doi.org/10.1016/j.vaccine.2011.04.098; PMID: 21571023
  • Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, et al, New Vaccine Surveillance Network (NVSN). Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis 2011; 53:245 - 53; http://dx.doi.org/10.1093/cid/cir307; PMID: 21705316
  • Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009; 124:465 - 71; http://dx.doi.org/10.1542/peds.2008-3528; PMID: 19581260
  • Curns AT, Panozzo CA, Tate JE, Payne DC, Patel MM, Cortese MM, et al. Remarkable postvaccination spatiotemporal changes in United States rotavirus activity. Pediatr Infect Dis J 2011; 30:Suppl S54 - 5; http://dx.doi.org/10.1097/INF.0b013e3181fefda9; PMID: 21183841
  • Braeckman T, Van Herck K, Raes M, Vergison A, Sabbe M, Van Damme P. Rotavirus vaccines in Belgium: policy and impact. Pediatr Infect Dis J 2011; 30:Suppl S21 - 4; http://dx.doi.org/10.1097/INF.0b013e3181fefc51; PMID: 21183836
  • Sáfadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, et al. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr Infect Dis J 2010; 29:1019 - 22; PMID: 20543761
  • Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev 1993; 15:265 - 302; PMID: 8174658
  • Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis 2011; 43:683 - 9; PMID: 21604922
  • Van Effelterre T, Soriano-Gabarró M, Debrus S, Claire Newbern E, Gray J. A mathematical model of the indirect effects of rotavirus vaccination. Epidemiol Infect 2010; 138:884 - 97; http://dx.doi.org/10.1017/S0950268809991245; PMID: 20028612
  • Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011; 30:Suppl S56 - 60; http://dx.doi.org/10.1097/INF.0b013e3181fefdc0; PMID: 21183842
  • Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204:980 - 6; http://dx.doi.org/10.1093/infdis/jir492; PMID: 21878425
  • Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s National Childhood vaccine schedule. Pediatr Infect Dis J 2011; 30:Suppl S25 - 9; http://dx.doi.org/10.1097/INF.0b013e3181fefdee; PMID: 21183837
  • Clarke MF, Davidson GP, Gold MS, Marshall HS. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine 2011; 29:4663 - 7; http://dx.doi.org/10.1016/j.vaccine.2011.04.109; PMID: 21575665
  • Macartney KK, Porwal M, Dalton D, Cripps T, Maldigri T, Isaacs D, et al. Decline in rotavirus hospitalisations following introduction of Australia’s national rotavirus immunisation programme. J Paediatr Child Health 2011; 47:266 - 70; http://dx.doi.org/10.1111/j.1440-1754.2010.01953.x; PMID: 21244557
  • Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, et al. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011; 29:2791 - 6; http://dx.doi.org/10.1016/j.vaccine.2011.01.104; PMID: 21320539
  • Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 2011; 30:Suppl S6 - 10; http://dx.doi.org/10.1097/INF.0b013e3181fefa05; PMID: 21048524
  • Anderson E. Deanna Shippee, Melissa Weinrobe, Melissa Davila, Ben Katz, Samuel Lee, Yael Simons, Mary Gene Cuyugan, M Gary Noskin, MD, Pediatric Rotavirus Vaccination Reduces Prevalence in Adults Infectious Diseases Society of America (IDSA) 49th Annual Meeting: Abstract LB-26. Presented October 22, 2011.
  • Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011; 378:1962 - 73; http://dx.doi.org/10.1016/S0140-6736(10)62225-8; PMID: 21492929
  • Zuccotti G, Meneghin F, Dilillo D, Romanò L, Bottone R, Mantegazza C, et al. Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy. BMC Infect Dis 2010; 10:218; http://dx.doi.org/10.1186/1471-2334-10-218; PMID: 20649961
  • Gurgel RQ, Correia JB, Cuevas LE. Effect of rotavirus vaccination on circulating virus strains. Lancet 2008; 371:301 - 2; http://dx.doi.org/10.1016/S0140-6736(08)60164-6; PMID: 18294994
  • Gurgel RQ, Cuevas LE, Vieira SCF, Barros VC, Fontes PB, Salustino EF, et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 2007; 13:1571 - 3; PMID: 18258011
  • Leite JP, Carvalho-Costa FA, Linhares AC. Group A rotavirus genotypes and the ongoing Brazilian experience: a review. Mem Inst Oswaldo Cruz 2008; 103:745 - 53; http://dx.doi.org/10.1590/S0074-02762008000800001; PMID: 19148411
  • Carvalho-Costa FA, Volotão EdeM, de Assis RM, Fialho AM, de Andrade JdaS, Rocha LN, et al. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009. Pediatr Infect Dis J 2011; 30:Suppl S35 - 41; http://dx.doi.org/10.1097/INF.0b013e3181fefd5f; PMID: 21048523
  • Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, et al, National Rotavirus Strain Surveillance System. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011; 30:Suppl S42 - 7; http://dx.doi.org/10.1097/INF.0b013e3181fefd78; PMID: 21183839
  • Desai SN, Vázquez M. Update on rotavirus trends and the importance of surveillance. Pediatr Infect Dis J 2010; 29:1130 - 2; http://dx.doi.org/10.1097/INF.0b013e3181ff1eeb; PMID: 21099653
  • Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia. Pediatr Infect Dis J 2011; 30:Suppl S48 - 53; http://dx.doi.org/10.1097/INF.0b013e3181fefd90; PMID: 21183840
  • Weinberg GA, Payne DC, Teel EN, Mijatovic-Rustempasic S, Bowen MD, Wikswo M, et al. First reports of human rotavirus G8P[4] gastroenteritis in the United States. J Clin Microbiol 2012; 50:1118 - 21; http://dx.doi.org/10.1128/JCM.05743-11; PMID: 22170918
  • World Health Organization. Rotavirus vaccines: an updateWeekly Epidemiological Record (WER) 18 December 2009, vol. 84, 50 (pp 533540). http://www.who.int/wer/2009/wer8451_52.pdf Accessed 19 February 2012.
  • Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou V, et al. Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries. Hum Vaccin 2011; 7:734 - 48; http://dx.doi.org/10.4161/hv.7.7.15511; PMID: 21734466
  • O’Ryan M, Lucero Y, Linhares AC. Rotarix®: vaccine performance 6 years postlicensure. Expert Rev Vaccines 2011; 10:1645 - 59; http://dx.doi.org/10.1586/erv.11.152; PMID: 22085167
  • Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30:Suppl S30 - 4; http://dx.doi.org/10.1097/INF.0b013e3181ffe3eb; PMID: 21183838
  • Staat MA, Payne DC, Donauer S, Weinberg GA, Edwards KM, Szilagyi PG, et al, New Vaccine Surveillance Network (NVSN). Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics 2011; 128:e267 - 75; http://dx.doi.org/10.1542/peds.2010-3722; PMID: 21768317
  • Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010; 125:e199 - 207; http://dx.doi.org/10.1542/peds.2009-1021; PMID: 20083525
  • Guh AY, Hadler JL. Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008. Vaccine 2011-2008; 29:6155 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.06.066; PMID: 21723356
  • Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, et al. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J 2010; 29:1133 - 5; http://dx.doi.org/10.1097/INF.0b013e3181ed18ab; PMID: 20634776
  • Snelling TL, Andrews RM, Kirkwood CD, Culvenor S, Carapetis JR. Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia. Clin Infect Dis 2011; 52:191 - 9; http://dx.doi.org/10.1093/cid/ciq101; PMID: 21288843
  • Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010; 126:e506 - 12; http://dx.doi.org/10.1542/peds.2010-0443; PMID: 20732946
  • Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children. Pediatr Infect Dis J 2010; 29:319 - 23; PMID: 19935446
  • Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011; 30:e120 - 5; http://dx.doi.org/10.1097/INF.0b013e318214b811; PMID: 21436757
  • Braeckman T, Van Herck K, Raes M, Vergison A, Sabbe M, Van Damme P. Rotavirus vaccines in Belgium: policy and impact. Pediatr Infect Dis J 2011; 30:Suppl S21 - 4; http://dx.doi.org/10.1097/INF.0b013e3181fefc51; PMID: 21183836
  • Castilla J, Beristain X, Martínez-Artola V, Navascués A, García Cenoz M, Alvarez N, et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine 2012; 30:539 - 43; http://dx.doi.org/10.1016/j.vaccine.2011.11.071; PMID: 22122860
  • Martinón-Torres F, Bouzón Alejandro M, Redondo Collazo L, Sánchez Lastres JM, Pértega Díaz S, Seoane Pillado MT, et al, ROTACOST research team. Effectiveness of rotavirus vaccination in Spain. Hum Vaccin 2011; 7:757 - 61; http://dx.doi.org/10.4161/hv.7.7.15576; PMID: 21521947
  • Gagneur A, Nowak E, Lemaitre T, Segura JF, Delaperrière N, Abalea L, et al, IVANHOE investigators. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study. Vaccine 2011; 29:3753 - 9; http://dx.doi.org/10.1016/j.vaccine.2011.03.035; PMID: 21443962
  • Uhlig U, Kostev K, Schuster V, Uhlig HH. Rotavirus vaccination in Germany: analysis of nationwide surveillance data 2006 to 2010. Pediatr Infect Dis J 2011; 30:e244 - 7; http://dx.doi.org/10.1097/INF.0b013e31822d1408; PMID: 21817956
  • Desai R, de Oliveira LH, Parashar UD, Lopman B, Tate JE, Patel MM. Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review. Mem Inst Oswaldo Cruz 2011; 106:907 - 11; PMID: 22241109
  • Bonkoungou IJ, Damanka S, Sanou I, Tiendrébéogo F, Coulibaly SO, Bon F, et al. Genotype diversity of group A rotavirus strains in children with acute diarrhea in urban Burkina Faso, 2008-2010. J Med Virol 2011; 83:1485 - 90; http://dx.doi.org/10.1002/jmv.22137; PMID: 21678452
  • Nokes DJ, Peenze I, Netshifhefhe L, Abwao J, De Beer MC, Seheri M, et al. Rotavirus genetic diversity, disease association, and temporal change in hospitalized rural Kenyan children. J Infect Dis 2010; 202:Suppl S180 - 6; http://dx.doi.org/10.1086/653566; PMID: 20684700
  • Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med 2011; 365:337 - 46; http://dx.doi.org/10.1056/NEJMoa1006261; PMID: 21793745
  • World Health Organization. Post-marketing surveillance of rotavirus vaccine safety. http://whqlibdoc.who.int/hq/2009/WHO_IVB_09.01_eng.pdf. Accessed 28 January 2012.
  • Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, et al, Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11 - 22; http://dx.doi.org/10.1056/NEJMoa052434; PMID: 16394298
  • Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al, Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23 - 33; http://dx.doi.org/10.1056/NEJMoa052664; PMID: 16394299
  • Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364:2283 - 92; http://dx.doi.org/10.1056/NEJMoa1012952; PMID: 21675888
  • Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, et al, PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29:3061 - 6; http://dx.doi.org/10.1016/j.vaccine.2011.01.088; PMID: 21316503
  • Zickafoose JS, Benneyworth BD, Riebschleger MP, Espinosa CM, Davis MM. Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States. Arch Pediatr Adolesc Med 2012; 166:350 - 5; http://dx.doi.org/10.1001/archpediatrics.2011.1501; PMID: 22213609
  • Escolano S, Farrington CP, Hill C, Tubert-Bitter P. Intussusception after rotavirus vaccination–spontaneous reports. N Engl J Med. 201;365:2139.
  • Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012; 307:598 - 604; http://dx.doi.org/10.1001/jama.2012.97; PMID: 22318281
  • Centers for Disease Control and Prevention. http://www.cdc.gov/vaccinesafety/vaccines/rotateq_intussusception.html. Accessed 30 January 2012.
  • Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, et al, Vaccine Safety Datalink Investigation Group. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J 2010; 29:1 - 5; http://dx.doi.org/10.1097/INF.0b013e3181af8605; PMID: 19907356
  • Geier DA, King PG, Sykes LK, Geier MR. The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS). Med Sci Monit 2012; 18:PH12 - 7; PMID: 22293889
  • Loughlin J, Mast TC, Doherty MC, Wang FT, Wong J, Seeger JD. Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine. Pediatr Infect Dis J 2012; 31:292 - 6; http://dx.doi.org/10.1097/INF.0b013e3182421390; PMID: 22173146

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.